Viral Vitalism

Rapid Briefs

Safety Watch

Drug quality, FDA warnings, compounding, recalls, device safety, and consumer health risk signals.

Regenerative MedicineDeveloping

An 18-Year-Old Burn Patient Received a World-First Exosome Treatment

Kaitlin Jeffrey reportedly avoided facial and neck skin grafting after experimental exosome injections, but this remains a single case, not established burn care.

Why now

A world-first patient story is drawing attention to exosomes as a possible regenerative tool in acute burn care.

Overclaim risk
high
Primary source
Official
Published
Jun 24, 2026
Drug SafetyConfirmed

The Compounded GLP-1 Boom Is Becoming a Patient-Safety and Trust Crisis

The weight-loss drug boom created a shadow market of compounded GLP-1s, fake labels, telehealth claims, dosing confusion, and patients who may not know what they are actually getting.

Why now

Regulatory warnings and investigations are converging on the same problem: patients cannot always tell what product they are receiving.

Overclaim risk
medium-high
Primary source
Trade news
Published
Jun 24, 2026
WearablesConfirmed

FDA Cleared the First Over-the-Counter Glucose Monitor for Children

Dexcom's Stelo Glucose Biosensor System is now cleared for over-the-counter use in people ages 2 and older who do not use insulin.

Why now

FDA clearance moves over-the-counter metabolic tracking into childhood for the first time.

Overclaim risk
medium
Primary source
Official
Published
Jun 24, 2026

Vital Signals

Get the weekly health signal without the wellness fog.

A clean weekly brief covering longevity science, fitness, nutrition, medicine, health culture, and the claims worth questioning.

No spam. No miracle claims. Just better health signal.

By subscribing, you agree to receive email from Viral Vitalism. Unsubscribe anytime. See our Privacy Policy.